Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Capital Leases (2016 - 2024)

Lifecore Biomedical, Inc. \De\ (LFCR) has 7 years of Capital Leases data on record, last reported at $3.2 million in Q2 2024.

  • For Q2 2024, Capital Leases changed 0.03% year-over-year to $3.2 million; the TTM value through May 2024 reached $3.2 million, changed 0.03%, while the annual FY2024 figure was $3.2 million, 0.03% changed from the prior year.
  • Capital Leases reached $3.2 million in Q2 2024 per LFCR's latest filing, roughly flat from $3.2 million in the prior quarter.
  • Across five years, Capital Leases topped out at $26.4 million in Q2 2020 and bottomed at $3.2 million in Q2 2023.
  • Average Capital Leases over 3 years is $9.1 million, with a median of $3.3 million recorded in 2020.
  • The widest YoY moves for Capital Leases: up 646.83% in 2020, down 2.67% in 2020.
  • A 3-year view of Capital Leases shows it stood at $26.4 million in 2020, then crashed by 87.82% to $3.2 million in 2023, then rose by 0.03% to $3.2 million in 2024.
  • Per Business Quant database, its latest 3 readings for Capital Leases were $3.2 million in Q2 2024, $3.2 million in Q2 2023, and $26.4 million in Q2 2020.